Mutation of the ras genes is a rare genetic event in the histologic transformation of follicular lymphoma

Leukemia

Volumn 10, Issue 5, 1996, Pages 844-847

  Clark, H M ^a   Yano, T ^a   Sander, C ^a   Jaffe, E S ^a   Raffeld, M ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Follicular lymphomas; Molecular pathogenesis; ras oncogenes; Transformation

Indexed keywords

AMINO ACID SUBSTITUTION; ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; FOLLICULAR LYMPHOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MUTATION RATE; ONCOGENE RAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 0029924788     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Ersboll J, Schultz HB, Pedersen BJ, Nissen NI. Follicular low-grade non-Hodgkin's lymphoma: long-term outcome with or without tumor progression. Eur J Haematol 1989; 42: 155-163.
2. Cullen MH, Lister TA, Brearley RI, Shand WS, Stansfeld AG, Histological transformation of non-Hodgkin's lymphoma: a prospective study. Cancer 1979; 44: 645-651.
3. Garvin AJ, Simon RM, Osborne CK, Merrill J, Young RC, Berard CW. An autopsy study of histologic progression in non-Hodgkin's lymphomas, 192 cases from the National Cancer Institute. Cancer 1983; 52: 393-398.
4. Risdall R, Hoppe RT, Warnke R. Non-Hodgkin's lymphoma: a study of the evolution of the disease based upon 92 autopsied cases. Cancer 1979; 44: 529-542.
5. Hubbard SM, Chabner BA, DeVita VJ, Simon R, Berard CW, Jones RB, Garvin AJ, Canellos GP, Osborne CK, Young RC. Histologic progression in non-Hodgkin's lymphoma. Blood 1982; 59: 258-264.
6. Oviatt DL, Cousar JB, Collins RD, Flexner JM, Stein RS. Malignant lymphomas of follicular center cell origin in humans. V. Incidence, clinical features, and prognostic implications of transformation of small cleaved cell nodular lymphoma. Cancer 1984; 53: 1109-1114.
7. Raffeld M, Wright JJ, Lipford E, Cossman J, Longo DL, Bakhshi A, Korsmeyer SJ. Clonal evolution of t(14;18) follicular lymphomas demonstrated by immunoglobulin genes and the 18q21 major breakpoint region. Cancer Res 1987; 47: 2537-2542.
8. Yano T, Jaffe ES, Longo DL, Raffeld M. MYC rearrangements in histologically progressed follicular lymphomas. Blood 1992; 80: 758-767.
9. Sander CA, Yano T, Clark HM, Harris C, Longo DL, Jaffe ES, Raffeld M. p53 mutation is associated with progression in follicular lymphomas. Blood 1993; 82: 1994-2004.
10. Lo Coco F, Gaidano G, Louie DC, Offit K, Chaganti RS, Dalla-Favera R. p53 mutations are associated with histologic transformation of follicular lymphoma. Blood 1993; 82: 2289-2295.
11. Barbacid M. ras genes. Annu Rev Biochem 1987; 56: 779-827.
12. Bos JL. ras oncogenes in human cancer: a review (published erratum appears in Cancer Res 1990; 50: 1352). Cancer Res 1989; 49: 4682-4689.
13. Needleman SW, Kraus MH, Srivastava SK, Levine PH, Aaronson SA. High frequency of N-ras activation in acute myelogenous leukemia. Blood 1986; 67: 753-757.
14. Bos JL, Verlaan-de Vries M, van der Eb AJ, Janssen JW, Delwel R, Lowenberg B, Colly LP. Mutations in N-ras predominate in acute myeloid leukemia. Blood 1987; 69: 1237-1241.
15. Browett PJ, Norton JD. Analysis of ras gene mutations and methylation state in human leukemias. Oncogene 1989; 4: 1029-1036.
16. Paquette RL, Berenson J, Lichtenstein A, McCormick F, Koeffler HP. Oncogenes in multiple myeloma: point mutation of N-ras. Oncogene 1990; 5: 1659-1663.
17. Ahuja HG, Foti A, Bar EM, Cline MJ. The pattern of mutational involvement of RAS genes in human hematologic malignancies determined by DNA amplification and direct sequencing. Blood 1990; 75: 1684-1690.
18. Portier M, Moles JP, Mazards GR, Jeanteur P, Bataille R, Klein B, Theillet C. p53 and RAS gene mutations in multiple myeloma. Oncogene 1992; 7: 2539-2543.
19. Neri A, Knowles DM, Greco A, McCormick F, Dalla-Favera R. Analysis of RAS oncogene mutations in human lymphoid malignancies. Proc Natl Acad Sci USA 1988; 85: 9268-9272.
20. Imamura N, Kuramoto A, Ishihara H and Shimizu S. H-RAS point mutations in leukaemias and lymphomas (letter). Lancet 1992; 339: 1297-1298.
21. Sklar MD, Kitchingman CR. Isolation of activated ras transforming genes from two patients with Hodgkin's disease, Int J Radiat Oncol Biol Phys 1985; 11: 49-55.
22. Wodnar-Filipowicz A, Senn HP, Jiricny J, Signer E, Moroni C. Glycine-cysteine substitution at codon 13 of the N-ras proto-oncogene in a human T cell non-Hodgkin's lymphoma. Oncogene 1987; 1: 457-461.
23. Wodnar-Filipowicz A, Senn HP, Jiricny J, Signer E, Moroni C. Amino acid substitution at position 13 of the N-ras gene in a non-Hodgkin's lymphoma patient. Hamatol Bluttransfus 1987; 31: 172-174.
24. Bos JL, Fearon EF, Hamilton SR, Verlaan-de Vries M, van Boom JH, van der Eb AJ, Vogelstein B. Prevalence of ras gene mutations in human colorectal cancers. Nature 1987; 327: 293-297.
25. Ball NJ, Yohn JJ, Morelli JG, Norris DA, Golitz LE, Hoeffler JP. Ras mutations in human melanoma: a marker of malignant progression. J Invest Dermatol 1994; 102: 285-290.
26. Suzuki Y, Orita M, Shiraishi M, Hayashi K, Sekiya T. Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene 1990; 5: 1037-1043.
27. Raffeld M, Jaffe ES. Identification of cells in tissue sections. In: Coligan JE, Kruisbeck AM, Margulies DH, Shevach EM, Strober W (eds) Current Protocols in Immunology. John Wiley and Sons: New York, 1994, pp 5.8.1-5.8.8.
28. Raquette RL, Landaw EM, Pierre RV, Kahan J, Lubbert M, Lazcano O, Isaac G, McCormick F, Koeffler HP. N-ras mutations are associated with poor prognosis and increased risk of leukemia in myelodysplastic syndrome. Blood 1993; 82: 590-599.
29. Lubbert M, Mirro J Jr, Kitchingman G, McCormick F, Mertelsmann R, Herrmann F, Koeffler HP. Prevalence of N-ras mutations in children with myelodysplastic syndromes and acute myeloid leukemia. Oncogene 1992; 7: 263-268.
30. Lubbert M, Mirro J Jr, Miller CW, Kahan J, Isaac G, Kitchingman G, Mertelsmann R, Herrmann F, McCormick F, Koeffler HP. N-ras gene point mutations in childhood acute lymphocytic leukemia correlate with a poor prognosis. Blood 1990; 75: 1163-1169.
31. Ballerini P, Gaidano G, Gong JZ, Tassi V, Saglio G, Knowles DM, Dalla-Favera R. Multiple genetic lesions in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Blood 1993; 81: 166-176.